PEP-Therapy
Isabelle Ray-Coquard is a Medical oncologist in the Comprehensive Cancer Center Leon Bérard (CLB) and Professor of Medical Oncology at University Claude Bernard Lyon I. President of the GINECO group (Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du sein) and Network Director of the national observatory dedicated to rare ovarian cancer.
This person is not in the org chart
This person is not in any offices
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.